UnitedHealth Group Incorporated (NYSE:UNH) was downgraded by research analysts at ValuEngine from a “buy” rating to a “hold” rating in a report released on Thursday.

Other analysts have also issued research reports about the company. Sanford C. Bernstein reiterated an “outperform” rating and issued a $190.00 target price on shares of UnitedHealth Group in a research note on Monday, July 10th. Credit Suisse Group reiterated an “outperform” rating and issued a $200.00 target price (up previously from $195.00) on shares of UnitedHealth Group in a research note on Thursday, July 13th. Cantor Fitzgerald reiterated a “buy” rating and issued a $205.00 target price on shares of UnitedHealth Group in a research note on Friday, July 7th. Citigroup Inc. raised their price target on UnitedHealth Group from $195.00 to $213.00 and gave the company a “buy” rating in a research note on Wednesday, July 19th. Finally, Royal Bank Of Canada restated a “buy” rating and set a $212.00 price target on shares of UnitedHealth Group in a research note on Thursday, July 20th. Three research analysts have rated the stock with a hold rating and twenty-three have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $203.59.

UnitedHealth Group (NYSE:UNH) opened at 198.06 on Thursday. UnitedHealth Group has a 12 month low of $133.03 and a 12 month high of $200.76. The stock has a market capitalization of $191.50 billion, a P/E ratio of 23.79 and a beta of 0.63. The firm’s 50-day moving average is $196.36 and its 200-day moving average is $183.56.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, topping analysts’ consensus estimates of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The business had revenue of $50.05 billion for the quarter, compared to analyst estimates of $49.97 billion. During the same quarter last year, the firm posted $1.96 earnings per share. The business’s revenue was up 7.7% compared to the same quarter last year. On average, equities analysts expect that UnitedHealth Group will post $9.87 earnings per share for the current fiscal year.

WARNING: “UnitedHealth Group Incorporated (UNH) Rating Lowered to Hold at ValuEngine” was first posted by Watch List News and is the property of of Watch List News. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this news story can be read at https://www.watchlistnews.com/unitedhealth-group-incorporated-unh-rating-lowered-to-hold-at-valuengine/1614183.html.

In related news, Director Richard T. Burke sold 15,000 shares of UnitedHealth Group stock in a transaction dated Monday, August 21st. The stock was sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the completion of the sale, the director now owns 1,818,898 shares of the company’s stock, valued at $348,700,935.58. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction dated Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total value of $1,117,144.00. Following the sale, the director now directly owns 60,834 shares of the company’s stock, valued at approximately $12,135,774.66. The disclosure for this sale can be found here. In the last three months, insiders sold 76,174 shares of company stock valued at $14,981,909. Corporate insiders own 0.89% of the company’s stock.

Several institutional investors have recently added to or reduced their stakes in UNH. Patriot Financial Group Insurance Agency LLC lifted its holdings in shares of UnitedHealth Group by 1,722.9% during the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock worth $106,000 after purchasing an additional 603 shares during the period. Blue Chip Partners Inc. acquired a new stake in shares of UnitedHealth Group during the second quarter worth about $110,000. Kings Point Capital Management lifted its holdings in shares of UnitedHealth Group by 27.9% during the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock worth $113,000 after purchasing an additional 150 shares during the period. Bruderman Asset Management LLC acquired a new stake in shares of UnitedHealth Group during the second quarter worth about $114,000. Finally, Mitsubishi UFJ Securities Holdings Co. Ltd. lifted its holdings in shares of UnitedHealth Group by 433.3% during the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after purchasing an additional 520 shares during the period. 86.19% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.